Abstract: I welcome you to the fourth issue of the IEEE Communications Surveys and Tutorials in 2021. This issue includes 23 papers covering different aspects of communication networks. In particular, ...

In patients with pre-existing cardiovascular disease and who are overweight or obese, but who do not have diabetes, 2.4 mg of subcutaneous semaglutide taken once weekly was superior to placebo in ...

Mohammed Shami's tale has taken a new twist Shami has not played for India since March Shami had claimed he had no communication from the selectors The curious case of Mohammed Shami has seen another ...

"A ship is safe in harbour, but that is not what ships are for." This timeless wisdom speaks to a core dilemma of human endeavour: the choice between safety and potential reward. A ship anchored ...

Sarfaraz Khan, a consistent domestic performer, endured a disappointing one-run outing against Chhattisgarh. This follows his recent omission from the India A squad, sparking debate. Despite the ...

Abstract: Operational researchers and decision modelers have aspired to optimization technologies with a self-adaptive mechanism to cope with new problem formulations. Self-adaptive mechanisms not ...

Have you ever found yourself tangled in the complexities of popular CSS frameworks like Bootstrap or Tailwind, only to realize you’re using just a fraction of their features? You’re not alone. While ...

a) Record Date: The record date for the spin-off is November 18, 2024. b) Split Ratio: Shareholders will receive approximately 0.806971 shares of Concentra’s common stock for each share of Select ...

We want to inform you about an important update concerning University of Utah Health’s inclusion in your Select Health Medicare Advantage plan. Our contract to be “in-network” is currently under ...

20-year-old Katie loves tutorial porn. The university student, who is using her first name only for privacy reasons, tells Mashable that it helped her to understand sex during a time where it ...

Subcutaneous once-weekly semaglutide 2.4 mg, a GLP1 receptor agonist, was associated with a statistically significant 20% reduction in major adverse cardiovascular events (MACE) compared with placebo, ...